MedTech Dive, August 10, 2026: MedTech Dive describes MDUFA Commitment letter for medical device user fees and public FDA meeting. The article quotes CDRH as happy with collaboration, AdvaMed (medical device industry) happy with the decisions, and Diana Zuckerman and other patient and consumer advocates wanting more evidence of safety and effectiveness for all medical devices.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Breast implant removal is more popular than ever. Why?
National Geographic July 13, 2026: This fascinating history of breast implants explains how cultural views of breasts have changed over hundreds of years, resulting in the popularity of breast implants and now making implants’ surgical removal more popular than ever.
Read More »Next FDA chief to face similar headwinds after Makary’s ouster
The Hill, May 14, 2026: The next FDA Commissioner will face the same MAHA-MAGA challenges that Marty Makary did, including political interference, funding cuts, and White House interference. NCHR President Diana Zuckerman notes that although Makary offended just about everybody, he lost his job over a few actions (or lack of actions) that the White House did not like, and urges a more scientific, evidence-based FDA rather than one that bends to political appointees, donors, and friends of the White House.
Read More »Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in
STAT News, May 12, 2026: This article describes reasons for the resignation of FDA commissioner Marty Makary. NCHR president Diana Zuckerman calls him the worst FDA commissioner in 40 years because he undermined the scientific credibility of the agency; it became impossible to believe anything he said or the agency decided.
Read More »F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure
The New York Times, May 12, 2026: FDA Commissioner Makary resigns under pressure after offending almost everyone involved in FDA issues. NCHR president Diana Zuckerman explains that this resignation is inevitable but will be a disaster for the FDA if he is replaced by someone who is selected to primarily please tobacco, anti-abortion, and other industry lobbyists.
Read More »